Malaria Diagnostics Market Overview, Global Scope, SWOT Analysis and Forecast to 2023

 Market Analysis:

The global malaria diagnostics market is predicted to grow at a 4.6% CAGR over the forecast period (2018-2023), states the latest Market Research Future (MRFR) report. Malaria is a life-threating disease resulting from a parasite that is transmitted from the bite of infected anopheles’ mosquitoes. These infected mosquitoes transport the parasite. The moment such infected mosquitoes bite a person, the parasite gets released into their bloodstream. As the body becomes the host of these parasites, this passes to the liver and then matures. The mature parasites after a couple of days enter the bloodstream and begin infecting the red blood cells. People suffering from malaria experience weakness, headache, fever, and vomiting.

Malaria diagnostics is made through the microscopic test of the blood samples. Fever and other signs similar to malaria demand careful evaluation for diagnosing malaria. This diagnosis includes identifying antigens/products or malaria parasites in the patient’s blood. Accurate and prompt diagnosis is crucial for effective malaria management. Malaria diagnosis systems of superior quality is essential in every setting as misinterpretation or misdiagnosis can lead to mortality and substantial morbidity.

Access Full Report Details and Full TOC Exclusively @ https://www.marketresearchfuture.com/reports/malaria-diagnostics-market-6432

Key Players:

·         Bio-Rad Laboratories Inc
·         Olympus Corporation
·         Nikon Corporation
·         Leica Microsystems GmbH
·         Siemens Healthineers
·         Beckman Coulter Inc
·         BioMérieux
·         Sysmex Partec GmbH
·         Premier Medical Corporation Pvt
·         Abbott Laboratories
·         and Access Bio. Inc.

Market Segmentation:
·         The MRFR report offers a wide segmental analysis of the malaria diagnostics market on the basis of end user and technology.
·         Based on technology, the malaria diagnostics market is segmented into molecular diagnostics tests, microscopy, and rapid diagnostic tests.
·         Based on end users, the malaria diagnostics market is segmented into community healthcare, clinics, hospitals, and others.

Regional Analysis:
Based on the region, the Malaria Diagnostics Market report covers the latest trends and growth opportunities across the Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will dominate the market over the forecast period. This is owing to medical tourism, technological advancement, and healthcare awareness.

The malaria diagnostics market in Europe is predicted to have the second-largest share in the market over the forecast period. This is owing to the malaria cases brought by refugees and tourists in the European region.

The malaria diagnostics market in the APAC region is predicted to grow at the fastest pace over the forecast period. This is owing to the growing elderly population, changing lifestyle, and increasing patient population. Moreover, rising awareness and increasing funding from governments, private sectors, and care-based surveillance systems are also pushing market growth.

Industry Updates:

January 2019: Pioneers of innovative and rapid diagnostic solutions for early infectious disease detection ERADA Technology Alliance Ltd has launched the world’s first-ever saliva test to diagnose malaria.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more